A paper with contributions of QuoData’s scientists is now published on the Journal of Veterinary Diagnostic Investigation. The paper describes an interlaboratory comparison (ILC), which was performed in collaboration of several institutions (including QuoData), to help the laboratories evaluate their SARS-CoV2 test methods.
By conducting the ILC, a profound contribution was made to protect human and animal health by demonstrating the validity and performance of current SARSCoV2 RNA tests during the challenging times of the COVID19 pandemic. Prompted by the ILC study, further studies were already conducted and will be conducted in the future to get an unequivocal picture of key factors affecting test results, ultimately contributing to the advancement of pathogen detection.
The ILC was collaboratively conducted by:
- FDA–Center for Veterinary Medicine–Veterinary Laboratory Investigation and Response Network (Vet-LIRN)
- Moffett Proficiency Testing (PT) Laboratory and the FDA Division of Food Processing Science and Technology,
- U.S. Geological Survey (USGS),
- QuoData GmbH,
- U.S. Department of Agriculture (USDA) – National Animal and Plant Health Inspection Service (APHIS) Laboratories and National Animal Health